Vivus (VVUS +9%) spikes to a year high on the back of the the FDA's approval of Arena...

Vivus (VVUS +9%) spikes to a year high on the back of the the FDA's approval of Arena Pharmaceuticals' (ARNA +38%) weight-loss drug Belviq. Regulators are set to make a decision on its Qnexa diet drug on July 17.

From other sites
Comments (5)
  • phemale60
    , contributor
    Comments (3034) | Send Message
    Yes, I will be on a cruise down Mexico way, so that day will be extra special to me! Viva VVUS!
    27 Jun 2012, 03:16 PM Reply Like
  • karlis44
    , contributor
    Comments (63) | Send Message
    Belvig is a weak drug, about 2% wt loss. Affects Serotonin function to decrease appetite. May be problematic like Fenfluoramine?
    Phenteramine + Topomax = Qnexa- VVUS will likely be approved next has 10% wt loss over 2 yrs. FDA desperate to approve something for wt loss. Likely Belviq will have same fate as Orlistat - long term
    Karlis Ullis, MD
    Santa Monica ,CA 90405
    27 Jun 2012, 04:35 PM Reply Like
  • Chemist357
    , contributor
    Comments (280) | Send Message


    Good luck with the REMS, women from 18-45 years of age will be excluded from taking Qnexa. If you like Phenteramine + Topiramate then prescribe the generics. I would assume most docs would not want the liability of cleft lip and even more cardiovascular risk, in a patient already at increased risk due to obesity. Though I guess there is a reason why reckless doctors pay such high malpractice insurance. ARENA best day might be…when Qnexa is rejected due to side effect profile.
    Bough VVUS at 10.76 Sold VVUS at 25.00, bought Arena at 1.8…long Arena
    28 Jun 2012, 02:20 AM Reply Like
  • phemale60
    , contributor
    Comments (3034) | Send Message
    If so dangerous then why successful weight loss prescribing Phen & Top separately, and still being prescribed? Why hasn't it been stopped? How many babies born with cleft palate during these past years? How many heart attacks?


    It seems logical the FDA panel wouldn't have given Qnexa a 20-2 positive vote if results from years of Phen/Top had been damaging.


    Can't have it both ways!
    2 Jul 2012, 11:31 AM Reply Like
  • phemale60
    , contributor
    Comments (3034) | Send Message
    Sorry, distracted at work, and I'm sure above makes little sense. I think you got the gist!
    2 Jul 2012, 12:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs